The Acute Pain SIG is one of 17 SIGs jointly managed by ANZCA, the Australian Society of Anaesthetists (ASA), and the New Zealand Society of Anaesthetists (NZSA) through the Anaesthesia Continuing Education (ACE) partnership.

We have developed a number of overarching educational principles that have guided our decision-making in relation to education and training during the COVID-19 pandemic.

We've created a dedicated grant for research in a range of aspects of professional practice, including simulation/education

The Rural SIG is one of 17 SIGs jointly managed by ANZCA, the Australian Society of Anaesthetists (ASA), and the New Zealand Society of Anaesthetists (NZSA) through the Anaesthesia Continuing Education (ACE) partnership.

The Training Accreditation Committee (TAC) implements council policy in relation to the accreditation of approved training sites (usually Approved Hospital Departments but also other sites such as retrieval services) and rotational training programs in anaesthesia, noting that...

The Trauma SIG exists to co-ordinate resources, provide education and deliver updates to anaesthetists who care for trauma patients as part of their regular clinical work, those who are occasionally required to deal with severe trauma, and those who have a developing interest ...

The Safety and Quality Committee works with fellows and ANZCA Council to support safe clinical practice in anaesthesia and pain medicine.

Ulimaroa is a heritage listed, 19th Century Italianate mansion, now incorporated into our Melbourne headquarters on St Kilda Road in Melbourne. It was purchased in September 1993, when the college was established.

We strongly encourage all trainees preparing for the ANZCA final exam to take advantage of the refresher courses and mock vivas we run in major centres around Australia and New Zealand.

Our clinical trials seek definitive answers to inform best practice and improve patient care and safety. Explore who we are; our strategic priorities; our history and funding achievements; major findings from our published trials; and important research questions underway.